• Evinacumab: a new option in the treatment of homozygous familial hypercholesterolemia.
  Pirillo Angela et al. Expert opinion on biological therapy 2022
• A scoping review of interventions increasing screening and diagnosis of familial hypercholesterolemia.
  Polanski Amanda et al. Genetics in medicine : official journal of the American College of Medical Genetics 2022 6
• Comparison of Equations for the Calculation of LDL-Cholesterol in Familial Hypercholesterolemia: Data from Iranian Registry.
  Vaseghi Golnaz et al. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir 2022 50(4) 270-275
• Healthcare worker-based opportunistic screening for familial hypercholesterolemia in a low-resource setting.
  Sharma Sonali et al. PloS one 2022 17(6) e0269605
• Long-Term Cardiovascular and Cerebrovascular Challenges Posed by COVID-19 in Patients With Familial Hypercholesterolemia.
  Vuorio Alpo et al. Frontiers in pharmacology 2022 13890141
• A Selective Screening Strategy Performed in Pre-School Children and Siblings to Detect Familial Hypercholesterolemia.
  Thajer Alexandra et al. Children (Basel, Switzerland) 2022 9(5)
• Genetic Variant ABCC1 rs45511401 Is Associated with Increased Response to Statins in Patients with Familial Hypercholesterolemia.
  Dagli-Hernandez Carolina et al. Pharmaceutics 2022 14(5)
• Recent Advances on Familial Hypercholesterolemia in Children and Adolescents.
  Mainieri Francesca et al. Biomedicines 2022 10(5)
• Incomplete Penetrance of Population-Based Genetic Screening Results in Electronic Health Record
  G Elhanan et al, Frontiers in Genetics, April 2022
• Estimated Yield of Screening for Heterozygous Familial Hypercholesterolemia With and Without Genetic Testing in US Adults.
  Bellows Brandon K et al. Journal of the American Heart Association 2022 e025192

More